![Michael D. Rogers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michael D.
Rogers served as Chief Development Officer at Chimerix, Inc. from 2013 to 2016, and at Pharmasset, Inc. from 2007 to 2012.
Prior to that, he was Vice President of the Viral Diseases Division at GSK Plc from 2001 to 2007.
Rogers holds a graduate and doctorate degree from The University of North Carolina at Charlotte.
Anciens postes connus de Michael D. Rogers
| Sociétés | Poste | Fin |
|---|---|---|
| CHIMERIX, INC. | Corporate Officer/Principal | 30/06/2016 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Corporate Officer/Principal | 13/01/2012 |
| GSK PLC | Corporate Officer/Principal | 01/01/2007 |
Formation de Michael D. Rogers
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
